Transcriptomics

Dataset Information

0

Gene Expression during Panobinostat Dosing


ABSTRACT: A clinical study evaluating the dosing of an oral HDACi panobinostat in patient infected with HIV-1. Dosing was 20 mg orally, 3 times weekly, every other week for a total of 8 weeks. Gene expression was evaluated in whole PBMCs at baseline (Visit 2), after 3 doses (Visit 4), 4 weeks after dosing (Visit 12) and 6 months after dosing (Visit 13) using the Affymetrix HTA 2.0 gene expression chip

ORGANISM(S): Homo sapiens

PROVIDER: GSE109792 | GEO | 2018/01/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA432059 | ENA
2014-04-09 | E-GEOD-56623 | biostudies-arrayexpress
2015-06-02 | GSE69410 | GEO
2016-03-01 | E-GEOD-76664 | biostudies-arrayexpress
2014-04-09 | GSE56623 | GEO
2024-09-08 | GSE276501 | GEO
2016-03-01 | GSE76664 | GEO
2017-09-01 | GSE102757 | GEO
2010-06-30 | E-GEOD-3625 | biostudies-arrayexpress
2015-12-31 | E-GEOD-68690 | biostudies-arrayexpress